Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Biocon Biologics and Serum Institute Life Sciences announce Strategic Alliance

Posted On: 2021-09-16 21:35:51 (Time Zone: IST)


Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd. today announced a strategic alliance.

Under the terms of the agreement, BBL will offer approximately 15% stake to SILS, at a post-money valuation of ~$4.9 billion, for which it will get committed access to a 100 million doses of vaccines per annum for 15 years, primarily from SILS's upcoming vaccine facility in Pune with commercialization rights of the SILS vaccine portfolio (including COVID-19 vaccines) for global markets.

Pursuant to the terms of the agreement, BBL will generate a committed revenue stream and related margins, commencing H2, FY23. Adar Poonawalla will have a Board seat in Biocon Biologics Limited.

In addition to vaccines, the strategic alliance will also develop antibodies targeting several infectious diseases like Dengue, HIV, etc. The two companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of the vaccines and antibodies.

Vaccines are a complementary business fit to BBL and provides a new dimension to its effort in improving global healthcare. Most recently, BBL announced a manufacturing and commercialization partnership in select emerging markets with Boston based Adagio Therapeutics Inc. for ADG20, a novel COVID-19 antibody therapy. These collaborations support Biocon Biologics' intent of straddling on both infectious and non-communicable diseases in its quest to impact global health.

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics, said: "This alliance will complement the strengths and resources of the two leading players in vaccines and biologics. Our shared vision of building large scale businesses having global impact makes it a unique and synergistic value creation opportunity."

Adar Poonawalla, CEO, Serum Institute of India, commented: "We look forward to complementing each other's capabilities and capacities in vaccines and biologics, with the objective of addressing inequitable access both in emerging and developed markets for life saving vaccines and biologics."

Biocon Biologics will also establish, at its cost, a vaccine R&D division to support the strategic alliance in developing both vaccines and biologics for communicable diseases. Additionally, wherever possible, it will make available its cell culture and sterile fill and finish capacities, for vaccine production under the strategic alliance.

Both companies believe that this is an alliance that can make significant impact on global healthcare through vaccines and biologics.

Shares of Biocon Ltd. was last trading in BSE at Rs. 376.9 as compared to the previous close of Rs. 357.35. The total number of shares traded during the day was 229012 in over 4241 trades.

The stock hit an intraday high of Rs. 379.05 and intraday low of 356. The net turnover during the day was Rs. 84991043.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

TVS Motor Company wins India Green Energy Award

Zuari Agro Chemicals Limited announces shutdown of NPK plants

Metropolis Healthcare completes acquisition of chain of labs in South India called 'Hitech Diagnostic Centre'

Ravi Kumar Distilleries Ltd resumes operations at factory

JK Cement Ltd and PRESPL sign a Strategic MoU to Curate a 'Decarbonisation Path', envisioned for Decade and Beyond

Bank of India opens first ever branch in Leh

Kotak Partners Pine Labs as it scales up its Merchant Acquiring Business

IndiGo transported 67.9% of the vaccines as India touches 100-crore dose milestone

Cybertech Systems and Software Ltd Q2FY22 consolidated PAT at Rs. 8.47 crore

Reliance Industries Ltd Q2FY22 consolidated PAT rises to Rs. 13680 crore

Dodla Dairy Ltd Q2FY22 consolidated net profit drops to Rs. 29.39 crore

Zenotech Laboratories Ltd posts Rs. 94.64 lakhs profit in Q2FY22

Inventure Growth and Securities Ltd Q2FY22 consolidated PAT at Rs. 3.70 crore

The Federal Bank Ltd reports consolidated PAT of Rs. 487.99 crore in Q2FY22

Crompton Greaves Consumer Electricals Ltd Q2FY22 consolidated PAT up at Rs. 158.81 crore

Tata Consumer Products Ltd consolidated Q2FY22 PAT at Rs. 268.04 crores

Pioneer Distilleries Ltd Q2FY22 loss at Rs. 21.79 crore

Tata Elxsi Ltd Q2FY22 net profit rises to Rs. 125.33 crore

Kirloskar Ferrous Industries Ltd posts Rs. 119.91 crores PAT in Q2FY22

Control Print Ltd posts Rs. 9.83 crore consolidated PAT in Q2FY22

Sacheta Metals Ltd Q2FY22 net profit at Rs. 0.42 crore

TCI Developers Ltd reports consolidated PAT at Rs. 14.35 lakhs

Huhtamaki India Ltd reports Q3CY21 loss at Rs. 21.84 crore

Garment Mantra Lifestyle Ltd opens 13th store at Surat, Gujarat

Globalspace Technologies Ltd Board recommends Final Dividend of Rs. 0.20

Prismx Global Ventures Ltd launches 'Gudgudi' The First OTT Channel

2021 TCS New York City Marathon App Lets Fans Enjoy a Hybrid Race Experience

Kranti Industries Ltd receives in-principle approval for migration to main board

B P Capital Ltd allots 30 lakh warrants

NALCO's Lean Slurry Project at Angul

Trimurthi Ltd acquires property in Hyderabad

Wendt India Ltd reports earnings for Q2FY22

Shanthi Gears Limited Q2 Revenue at Rs. 71.8 Crs and PBT Rs. 11.3 Crs

TCS & Shell Recognized with 2021 ISG Digital Case Study Award™ for Digital Transformation

Siemens Limited to procure solar power for Kalwa facility

Surana Solar Ltd invests in Surana Infotech Pvt Ltd

PVR announces results for the Quarter & Half Year ended September 30, 2021

Ramkrishna Forgings Ltd Opens Offices in Russia & Europe to further expand its global footprints

INOX Leisure Ltd - Q2'FY22 Financial Results Highlights

Steel Strips Wheels Ltd fixes Nov 22, 2021 as record date for stock split

Apollo Pipes Ltd Board recommends 2:1 Bonus Issue

TCI Express Ltd Board approves interim dividend of Rs. 3

Supreme Industries Ltd Board declares Interim Dividend of Rs. 6

Kajaria Ceramics Ltd Board declares Interim Dividend of Rs. 8

J. Kumar Infraprojects Ltd JV bags order worth Rs. 205.49 crore

Lupin life signs Hrlthik Roshan as the brand ambassador for Be One, Ayurvedic Energy Supplement

Welspun Corp Signs MoU With BP India Pvt. Ltd.

Adani Renewable Energy Holding Fifteen Ltd receives LOA from SECI for 450MW wind power project

The Indian Hume Pipe Company Limited receives LoA for Rs. 156.27 crores order

Zydus announces 'first patient' randomised in EVIDENCES-X Phase II(b) clinical trial of Saroglitazar Mg in NASH


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020